TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
09 07 2019
Historique:
accepted: 16 04 2019
revised: 03 04 2019
received: 13 10 2018
pubmed: 19 4 2019
medline: 26 2 2020
entrez: 19 4 2019
Statut: ppublish

Résumé

The liver-specific microRNA, miR-122, is an essential host factor for replication of the hepatitis C virus (HCV). miR-122 stabilizes the positive-strand HCV RNA genome and promotes its synthesis by binding two sites (S1 and S2) near its 5' end in association with Ago2. Ago2 is essential for both host factor activities, but whether other host proteins are involved is unknown. Using an unbiased quantitative proteomics screen, we identified the TNRC6 protein paralogs, TNRC6B and TNRC6C, as functionally important but redundant components of the miR-122/Ago2 host factor complex. Doubly depleting TNRC6B and TNRC6C proteins reduced HCV replication in human hepatoma cells, dampening miR-122 stimulation of viral RNA synthesis without reducing the stability or translational activity of the viral RNA. TNRC6B/C were required for optimal miR-122 host factor activity only when S1 was able to bind miR-122, and restricted replication when S1 was mutated and only S2 bound by miR-122. TNRC6B/C preferentially associated with S1, and TNRC6B/C depletion enhanced Ago2 association at S2. Collectively, these data suggest a model in which TNRC6B/C regulate the assembly of miR-122/Ago complexes on HCV RNA, preferentially directing miR-122/Ago2 to S1 while restricting its association with S2, thereby fine-tuning the spatial organization of miR-122/Ago2 complexes on the viral genome.

Identifiants

pubmed: 30997501
pii: 5475080
doi: 10.1093/nar/gkz278
pmc: PMC6614814
doi:

Substances chimiques

5' Untranslated Regions 0
AGO2 protein, human 0
Argonaute Proteins 0
MIRN122 microRNA, human 0
MicroRNAs 0
RNA, Viral 0
RNA-Binding Proteins 0
TNRC6B protein, human 0
TNRC6C protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

6411-6424

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI095690
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Nat Commun. 2018 Jul 4;9(1):2613
pubmed: 29973597
Nat Struct Mol Biol. 2008 Apr;15(4):346-53
pubmed: 18345015
Science. 2012 May 25;336(6084):1037-40
pubmed: 22539551
Science. 2005 Sep 2;309(5740):1577-81
pubmed: 16141076
Cell Host Microbe. 2014 Aug 13;16(2):257-264
pubmed: 25121753
Science. 2010 Jan 8;327(5962):198-201
pubmed: 19965718
J Virol. 2012 Jul;86(13):7372-83
pubmed: 22532678
Nucleic Acids Res. 2015 Sep 3;43(15):7447-61
pubmed: 26170235
N Engl J Med. 2013 May 2;368(18):1685-94
pubmed: 23534542
J Gen Virol. 2017 Feb;98(2):212-224
pubmed: 28008821
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):E3770-9
pubmed: 24043833
J Virol. 2015 May;89(9):4857-65
pubmed: 25673723
J Virol. 2011 Mar;85(5):2342-50
pubmed: 21177824
Nat Rev Microbiol. 2015 Sep;13(9):544-58
pubmed: 26256788
Nucleic Acids Res. 2018 Jun 1;46(10):5139-5158
pubmed: 29672716
J Virol. 2015 Jun;89(12):6294-311
pubmed: 25855736
Nucleic Acids Res. 2011 Sep 1;39(17):7716-29
pubmed: 21653556
Nat Med. 2014 Aug;20(8):927-35
pubmed: 25064127
Virology. 2013 Jan 20;435(2):472-84
pubmed: 23141719
PLoS Pathog. 2017 Oct 30;13(10):e1006694
pubmed: 29084265
Nucleic Acids Res. 2017 May 5;45(8):4743-4755
pubmed: 28082397
J Virol. 2014 Jul;88(13):7199-209
pubmed: 24719423
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4991-6
pubmed: 21383155
J Virol. 2011 Nov;85(22):12087-92
pubmed: 21917968
Nat Cell Biol. 2005 Dec;7(12):1261-6
pubmed: 16284623
RNA. 2013 Jan;19(1):17-35
pubmed: 23150874
Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):941-6
pubmed: 22215596
Cell Host Microbe. 2008 Jul 17;4(1):77-85
pubmed: 18621012
RNA. 2009 Jun;15(6):1059-66
pubmed: 19383768
Nucleic Acids Res. 2018 Oct 12;46(18):9776-9792
pubmed: 30053137
J Hepatol. 2006 Oct;45(4):529-38
pubmed: 16879891
Nucleic Acids Res. 2013 Jan;41(2):978-94
pubmed: 23172285
Mol Cell. 2011 Oct 7;44(1):120-33
pubmed: 21981923
Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1881-6
pubmed: 23248316
Mol Cell. 2017 Aug 17;67(4):646-658.e3
pubmed: 28781232
Hepatology. 2013 Jan;57(1):70-80
pubmed: 22898980
Cell Chem Biol. 2018 May 17;25(5):619-633.e5
pubmed: 29503206
Cell. 2015 Mar 12;160(6):1099-110
pubmed: 25768906
Annu Rev Biochem. 2010;79:351-79
pubmed: 20533884
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11841-5
pubmed: 26351695
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Nat Rev Genet. 2011 Feb;12(2):99-110
pubmed: 21245828
Annu Rev Biochem. 2011;80:273-99
pubmed: 21548781
J Virol. 2010 Jul;84(13):6615-25
pubmed: 20427538
Cell. 2018 May 3;173(4):946-957.e16
pubmed: 29576456
Cell Host Microbe. 2015 Feb 11;17(2):217-28
pubmed: 25662750
RNA. 2009 Jun;15(6):1078-89
pubmed: 19398495
J Virol. 1999 Feb;73(2):1165-74
pubmed: 9882318
EMBO J. 2008 Dec 17;27(24):3300-10
pubmed: 19020517
Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):8197-8202
pubmed: 30038017
Nat Struct Mol Biol. 2009 Nov;16(11):1160-6
pubmed: 19838187
J Virol. 2008 Aug;82(15):7624-39
pubmed: 18508894
Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3193-8
pubmed: 21220300
Nat Rev Genet. 2015 Jul;16(7):421-33
pubmed: 26077373
Mol Cell Biol. 2009 Aug;29(15):4144-55
pubmed: 19470757
RNA. 2009 May;15(5):781-93
pubmed: 19304925

Auteurs

You Li (Y)

Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Li Wang (L)

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Efraín E Rivera-Serrano (EE)

Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Xian Chen (X)

Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Department of Biochemistry and Biophysics, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Stanley M Lemon (SM)

Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH